Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS study. [electronic resource]
Producer: 20051130Description: 45-52 p. digitalISSN:- 0022-510X
- Adult
- Cross-Over Studies
- Disability Evaluation
- Disease Progression
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Interferon Type I -- administration & dosage
- Interferon beta-1a
- Interferon-beta -- administration & dosage
- Magnetic Resonance Imaging
- Male
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Prospective Studies
- Recombinant Proteins
- Recurrence
- Research Design
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.